Stay updated on Nivolumab & Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Ipilimumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A centralized 'Locations' section was added listing Florida, Indiana, Massachusetts, Pennsylvania, Tennessee, and Virginia, replacing the previous separate location subsections. The footer link 'HHS Vulnerability Disclosure' was removed and the page revision updated to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T17:15:20.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    PubMed publication text updated to reflect auto-fill from PubMed and the revision tag updated to v3.3.2. The previous, more detailed PubMed note and revision v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:53:19.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Deleted a general funding/operating-status notice; no study content, eligibility criteria, or results were affected.
    Difference
    0.4%
    Check dated 2025-11-17T17:48:42.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The update appears to be a visual/layout refresh without any changes to the study details like the title, condition, locations, enrollment, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:32:52.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a new government-funding operating-status notice; removed the old v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T17:19:46.000Z thumbnail image

Stay in the know with updates to Nivolumab & Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.